These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1737937)

  • 1. Analysis of the AP-1 sites in the IL-2 promoter.
    Jain J; Valge-Archer VE; Rao A
    J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC; Pober JS
    J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.
    Petrak D; Memon SA; Birrer MJ; Ashwell JD; Zacharchuk CM
    J Immunol; 1994 Sep; 153(5):2046-51. PubMed ID: 8051409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
    Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
    J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter-specific trans-activation and inhibition mediated by JunB.
    Hsu JC; Cressman DE; Taub R
    Cancer Res; 1993 Aug; 53(16):3789-94. PubMed ID: 8339292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 10-base pair protein binding site in the promoter of the hamster H3.2 gene required for the S phase dependent increase in transcription and its interaction with a Jun-like nuclear factor.
    Naeve GS; Sharma A; Lee AS
    Cell Growth Differ; 1992 Dec; 3(12):919-28. PubMed ID: 1472472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
    Wang J; Shannon MF; Young IG
    Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
    Gonsky R; Deem RL; Hughes CC; Targan SR
    J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
    Jenkins F; Cockerill PN; Bohmann D; Shannon MF
    J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.
    Castellanos MC; Muñoz C; Montoya MC; Lara-Pezzi E; López-Cabrera M; de Landázuri MO
    J Immunol; 1997 Dec; 159(11):5463-73. PubMed ID: 9580241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.